IDO1 Antikörper (Internal Region)

Produktnummer ABIN185488

Dieses Ziege Polyklonal-Antikörper erkennt spezifisch IDO1 in WB, ELISA und IHC. Er zeigt eine Reaktivität gegenüber Human und wurde in 1 Publikation erwähnt.

Kurzübersicht für IDO1 Antikörper (Internal Region) (ABIN185488)

Target: IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser IDO1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Güteklasse: Verified

Produktdetails anti-IDO1 Antikörper

Bindungsspezifität: Internal Region

Verwendungszweck: INDO / IDO

Sequenz: CVLANWKKKD PNK

Kreuzreaktivität: Hund, Human, Maus, Ratte

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: Peptide with sequence CVLANWKKKDPNK, from the internal region of the protein sequence according to NP_002155.1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry: Paraffin embedded Human Placenta. Recommended concentration: 4-6 μg/mL.

Western Blot: Approx 50 kDa band observed in Human Lymph Node, Spleen and Placenta lysates (calculated MW of 45.3 kDa according to NP_002155.1). Recommended concentration: 0.5-1.5 μg/mL. Primary incubation was 1 hour. Preliminary testing was unsuccessful on

Peptide ELISA: antibody detection limit dilution 1:128000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Referenzen für anti-IDO1 Antikörper (ABIN185488)

Mohamed, Aboul-Fotouh, Ibrahim, Shehata, Mansour, Yassin, El-Eraky, Abdel-Tawab et al.: "Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-? and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic ..." in: Neuropsychiatric disease and treatment, Vol. 9, pp. 697-708, (2013) (PubMed).

Details zu IDO1

Target: IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Andere Bezeichnung: IDO1

Hintergrund: IDO1, INDO, indoleamine-pyrrole 2,3 dioxygenase, HGNC:6059, CD107B, IDO, Indoleamine 2,3-dioxygenase, indole 2,3-dioxygenase

Gen-ID: 3620

NCBI Accession: NP_002155

Pathways: Activated T Cell Proliferation